This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Africa

  1. Women in Uganda trying contraceptive self-injection for the first time share invaluable perspectives on practicing self-care for sexual and reproductive health.
    Published: November 2019
    Type: Article
  2. DRC is the first Gavi-supported country in Africa to introduce ROTASIIL®, a newly available heat-stable rotavirus vaccine made in India.
    Published: October 2019
    Type: Article
  3. This report summarizes findings from a descriptive study using quantitative and qualitative methods. The quantitative methods included a cross-sectional farm assessment survey using a standardized questionnaire, and collection of surveillance data on travel history in malaria cases from individual patient logs from the outpatient department register book. Qualitative methods employed were key informant interviews, focus group discussions, and direct observations
    Published: October 2019
    Type: Resource Page
  4. Subcutaneous DMPA (DMPA-SC, brand name Sayana Press) is an innovative injectable contraceptive that can dramatically expand access and choice for women. Led by PATH and John Snow Inc., the DMPA-SC Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product. For more information, visit the DMPA-SC Access Collaborative page or email FPoptions@path.org.
    Published: October 2019
    Type: Resource Page
  5. Ethiopia’s progress towards reducing the malaria burden is an inspiring public health success story, and a source of potential learning for other countries on the path to elimination. This case report describes Ethiopia’s three major success factors— (1) committed national leadership and partnership support, (2) scale-up of activities to support national control and elimination targets, and (3) the extension of prevention to the communities— and explores several exciting new opportunities to consolidate and expand upon Ethiopia’s decade of impact.
    Published: October 2019
    Type: Resource Page
  6. The STANDARD™ G6PD has achieved provisional Expert Review Panel for Diagnostics (ERPD) approval, which enables procurement with Global Fund and Unitaid funds. Point-of-care diagnostics for G6PD deficiency play a critical role in supporting appropriate treatment of Plasmodium vivax malaria and efforts to eliminate the disease.
    Published: October 2019
    Type: Article
  7. We make vaccines affordable for low-resource countries—and so do our partners
    Published: October 2019
    Type: Article
  8. This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.
    Published: September 2019
    Type: Resource Page
  9. The European Union (EU) is a critical investor in the global effort to develop innovative solutions to the world's biggest health challenges. This two-page brief covers the EU's history of supporting global health research and innovation, and lays out some next steps to build on this leadership and support a strong EU-Africa partnership.
    Published: September 2019
    Type: Resource Page
  10. PATH’s 2018 annual report describes our work to create a healthier, more equitable world.
    Published: September 2019
    Type: Article
Load more